Patents by Inventor WAN-I KUO

WAN-I KUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170319723
    Abstract: Disclosed herein is a radioimmune complex comprising an epidermal growth factor receptor (EGFR)-targeted antibody and a radioactive isotope of rhenium labeled thereon. The EGFR-targeted antibody is cetuximab or panitumumab.
    Type: Application
    Filed: May 3, 2017
    Publication date: November 9, 2017
    Inventors: WAN-I KUO, KAI-HUNG CHENG, YI-SHU HUANG, SHENG-NAN LO, YA-JEN CHANG, TSUNG-TSE WU, WEI-CHUAN HSU, MING-HSIN LI, CHIH-HSIEN CHANG
  • Patent number: 9775920
    Abstract: The present invention relates to a novel use of N-(4-isopropylphenyl)-5-amino-isoindoline for diagnosing Alzheimer's disease and quantifying amyloid in the brain.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: October 3, 2017
    Assignee: INSTITUTE OF NUCLEAR ENERGY RESEARCH, ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN, R.O.C.
    Inventors: Wan-I Kuo, Jian-Hua Zhao, Kang-Wei Chang, Tsai-Yueh Luo, Wei-Hsi Chen
  • Publication number: 20170028087
    Abstract: The present invention relates to a novel use of N-(4-isopropylphenyl)-5-amino-isoindoline for diagnosing Alzheimer's disease and quantifying amyloid in the brain.
    Type: Application
    Filed: July 29, 2016
    Publication date: February 2, 2017
    Inventors: WAN-I KUO, JIAN-HUA ZHAO, KANG-WEI CHANG, TSAI-YUEH LUO, WEI-HSI CHEN